RIDGE MANOR, Fla. — A new study suggests that cannabis use among seniors is at an all-time high. Research published in the ...
Stockhead on MSN
Biocurious: Inhalerx hones in on pot for pain and panic in its quest for historic drug approval
ASX minnow InhaleRX (ASX:IRX) is seeking to achieve what has eluded dozens of other cannabis plays: to regulatory approval.
IN, that finally gets CBD into the brain effectively. In mice, it relieved neuropathic pain quickly and didn’t cause the ...
From the column: "The whole regime of state-level 'medical' marijuana programs is based on political decisions, not science." ...
Independent Sydney MP Alex Greenwich says it is time to "get the ball rolling" on medical cannabis reforms in NSW.
Tuomi, said Haraschuk, developed post-traumatic stress disorder, depression disorder, anxiety disorder, and bipolar disorder.
Scientific interest in cannabis has accelerated at an unprecedented pace, with 2025 producing more peer-reviewed research ...
But there’s another feel-good neurotransmitter that’s gaining some attention on social media: anadamide. This compound, also known as the “bliss molecule,” is building a reputation for producing ...
(or home equivalents) emptied. In 2023, there were 301 opioid-related overdose deaths in Alameda County. Standing alone, that ...
Politicians — and human beings, in general — are profoundly reactive creatures. And in politics especially, there is a built-in incentive to look like you’re sprinting heroically toward a crisis.
A Maryland task force found that it is safe to use natural psychedelics for some medical treatments. Over the past year, the ...
Opinion
17hon MSNOpinion
I'm the cofounder and CEO of a THC drink company. Congress's hemp crackdown should be a wake-up call for the industry.
Jake Bullock, CEO of Cann, said the new hemp restrictions show that a bill regulating THC drinks and that the industry needs to wake up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results